CeGaT GmbH
CeGaT is a provider of genetic diagnostics and NGS services.
CeGaT is a global provider of genetic analyses for a wide range of medical, research, and pharmaceutical applications.
Founded in 2009 in Tübingen, Germany, the company combines stateof-the-art sequencing technology with medical expertise - with the aim of identifying the genetic causes of diseases and supporting patient care. For researchers and pharmaceutical companies, CeGaT offers a broad portfolio of sequencing services and tumor analysis. CeGaT generates the data basis for clinical studies and medical innovations and drives science forward with its own insights.
The owner-managed company stands for independence, comprehensive personal customer service, and outstanding quality. CeGaT‘s laboratory is accredited according to CAP/CLIA and DIN EN ISO 15189, and thus meets the highest international standards. In order to obtain first-class results, all processes are carried out in-house under scientific supervision.
| Category | Biotechnology |
|---|---|
| Working areas | Biotechnology, Diagnostics, Genetics, Oncology, Sequencing |
| Year of foundation | |
| Employees |
Contact
Paul-Ehrlich-Str. 23
72076 Tübingen
+49 7071 565 44 55
info@cegat.de
https://www.cegat.de/
News
CeGaT and Twist Bioscience Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease
New Service: Single-Cell Immune Profiling for an In-Depth Understanding of the Immune System
CeGaT’s Research and Pharma Solutions business unit has launched Single-Cell Immune Profiling, a new product to study the immune system on single-cell resolution. By providing…
CeGaT Tests for Active Corona Infections
Since October 1, anyone who would like to (or has to) be tested for active corona infections can come to CeGaT’s premises without prior appointment. The result is available within…
Update and Extension of the Panel for Genetic Eye Diseases
CeGaT has updated and expanded the Diagnostic Panel for Genetic Eye Diseases. As part of the regular updates, the panel was revised according to the current scientific knowledge,…